Valneva SE (VALN) Invested Capital (2020 - 2025)

Valneva SE's (VALN) quarterly Invested Capital came in at $208.6 million in Q4 2025, up 4.18% year-on-year from $200.2 million in Q4 2024, and up 4.18% quarter-over-quarter from $200.2 million in Q4 2024.

Valneva SE (VALN) Invested Capital (2020 - 2025) Analysis & Trends

Valneva SE has disclosed Invested Capital across 6 years of filings, most recently posting $208.6 million for Q4 2025.

  • Invested Capital for Q4 2025 came in at $208.6 million, up 4.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $208.6 million (down 5.88% YoY), and the FY2025 annual result was $208.6 million, up 4.18% from the prior year.
  • Invested Capital came in at $208.6 million for Q4 2025 at Valneva SE, up from $200.2 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $315.2 million in Q4 2022 to a low of $21.4 million in Q2 2024.
  • The 5-year median for Invested Capital is $190.2 million (2023), against an average of $183.0 million.
  • Peak annual rise in Invested Capital reached 31.96% in 2023, while the deepest fall reached 42.82% in 2023.
  • Valneva SE's Invested Capital stood at $252.0 million in 2021, then advanced by 25.1% to $315.2 million in 2022, then slumped by 42.82% to $180.2 million in 2023, then climbed by 11.09% to $200.2 million in 2024, then gained by 4.18% to $208.6 million in 2025.
  • The last three Invested Capital figures came in at $208.6 million (Q4 2025), $200.2 million (Q4 2024), and $21.4 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 7.14 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 795.79 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 595,226.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 14.38 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.26 Bn 94.26 Bn - 502.95 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 208.60 Mn
Dec 31, 2024 200.23 Mn
Jun 30, 2024 21.39 Mn
Dec 31, 2023 180.24 Mn
Mar 31, 2023 219.80 Mn
Dec 31, 2022 315.24 Mn
Sep 30, 2022 166.35 Mn
Jun 30, 2022 99.51 Mn
Mar 31, 2022 166.56 Mn
Dec 31, 2021 252.00 Mn
Dec 31, 2020 347.16 Mn